News Ticker

[ November 30, 2023 ] Validation Engineer – PSC Biotech – Aliso Viejo, CA Los Angeles Biotech Jobs
[ November 30, 2023 ] Atara Biotherapeutics To Present Positive New Tab-cel® Clinical Data During Oral Session at ESMO Immuno-Oncology Annual Congress 2023 Los Angeles Biotech News
[ November 29, 2023 ] Hoag’s Cardiothoracic Surgery Team Earns Highest Distinction in Three Surgical Areas Los Angeles Biotech News
[ November 29, 2023 ] Dr. Lauren Papa Establishes Prestigious Scholarship for Aspiring Healthcare Professionals in Los Angeles, CA Los Angeles Biotech News
[ November 29, 2023 ] Dr. Jessica Clague DeHart of Claremont Graduate University and LYTE Foundation to receive data and findings of the important Health of Women (HOW) Study® and the Metastatic Breast Cancer Collateral Damage (MBCCD) Project Los Angeles Biotech News

Agendia® Collaborates with National Cancer Institute, SWOG Cancer Research Network for Phase III Trial; Led by University of Michigan’s Dr. Erin Cobain

October 31, 2023 Los Angeles Biotechnology Network News Los Angeles Biotech News Comments Off

SWOG S2206 will use MammaPrint® breast cancer recurrence test to examine response to immunotherapy in women with high-risk HR+ breast cancer. IRVINE, Calif. and AMSTERDAM, Oct. 31, 2023 /PRNewswire/ — Agendia, Inc., a global leader in innovative genomic technology and diagnostic tests,…

Click here to view original post

Copyright © 2023 Biotech Networks, LLC